Author(s)

Hossein Heidari¹, Alireza Salehi Fordoei^1,2, Mostafa Saffary³, Mehdi Shafiee Ardestani^4*

¹Department of HIV and Hepatitis B, Pasteur Institute of Iran, Tehran, Iran.
²Blood Transfusion Organization, Qom, Iran.
³Addiction Research Department, Kashan University of Medical Sciences, Kashan, Iran.
⁴Department of Radio-Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Today nanoparticles based drug delivery or imaging agents are extremely being investigated as a very powerful tool in early diagnostics or treatment of different kinds of cancers including prostate malignancies. Among the diverse developing nanomaterials, biocompatible biodegradable dendrimers and chitosan or PLGA (Poly Lactic-co-Glycolic Acid) derivatives are more considered due to their safer profiles. As a result, finding novel prostate imaging agents based on nano sized structures would be of high global interest which will be further discussed in this review.

PLGA, Dendrimer, Nanoparticles Based Drug Delivery or Imaging Agents, Prostate Malignancies

Heidari, H. , Fordoei, A. , Saffary, M. and Ardestani, M. (2015) Prostate Cancer’s Molecular Imaging by Targeting Based Nanoparticles: An Overview. Health, 7, 580-588. doi: 10.4236/health.2015.75069.